Predictive Factors for Autoimmune Pancreatitis Relapse After 3 Years of Maintenance Therapy
Open Access
- 1 November 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 47 (10) , 1337-1343
Abstract
Objectives: Oral corticosteroid treatment is the standard therapy for autoimmune pancreatitis (AIP) and is highly effective. However, relapse may occur during maintenance therapy (MT). We aimed to clarify the predictive factors for relapse after 3 years of MT for use in deciding on the continuation of long-term MT. Methods: Among 56 retrospectively recruited AIP patients who received corticosteroid remission induction therapy followed by MT for a minimum of 5 years, 38 subjects were enrolled after exclusion criteria and divided into the relapse group of patients who experienced relapse after 3 years of MT and the nonrelapse group of patients who did not. Results: According to multivariate analysis, at least 4 other organ involvement numbers at diagnosis (hazard ratio, 5.82; 95% confidence interval, 1.203–28.192) and IgG of 1400 mg/dL or greater at 3 years of MT (hazard ratio, 4.41; 95% confidence interval, 1.096–17.790) were predictive factors for relapse after MT for 3 years, with patients exhibiting both predictive factors having a higher cumulative relapse rate than those with 1 or fewer predictive factor. Conclusions: We uncovered 2 predictive factors for AIP relapse after 3 years of MT. These findings will assist in deciding corticosteroid therapy regimens at 3 years of MT to minimize AIP relapse risk and adverse corticosteroid effects.Keywords
This publication has 35 references indexed in Scilit:
- Clinical Characteristics of Patients with Autoimmune Pancreatitis with or without Mikulicz's Disease and Mikulicz's Disease AloneGut and Liver, 2013
- Type 1 Autoimmune Pancreatitis Can Transform into Chronic Pancreatitis: A Long-Term Follow-Up Study of 73 Japanese PatientsInternational Journal of Rheumatology, 2013
- Significance of Measuring IgG and IgG4 During Follow-Up of Autoimmune PancreatitisPancreas, 2011
- Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroidsJournal of Gastroenterology, 2011
- International Consensus Diagnostic Criteria for Autoimmune PancreatitisPancreas, 2011
- Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIPJournal of Gastroenterology, 2010
- Clinical Significance of Extrapancreatic Lesions in Autoimmune PancreatitisPancreas, 2010
- Standard steroid treatment for autoimmune pancreatitisGut, 2009
- Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatmentGut, 2007
- Autoimmune pancreatitis: proposal of IgG4-related sclerosing diseaseJournal of Gastroenterology, 2006